Analyst Reports

EverBlu Capital Research Report: A Closer Look at Nyrada - a Noxopharm subsidiary company.
Noxopharm Research Report prepared by EverBlu Capital Research July 2018
NOX Research Report prepared by APP Securities
Independent Investment Research Report May 2017
Independent Investment Research Report November 2016
APP Securities Company Research Report September 2016